L A DiMeglio1, L G Kanapka2, D J DeSalvo3, B J Anderson3, K R Harrington4, M E Hilliard3, L M Laffel4, W V Tamborlane5, M A Van Name5, R P Wadwa6, S M Willi7, S Woerner1, J C Wong8, K M Miller2. 1. Indiana University School of Medicine, Indianapolis, IN, USA. 2. Jaeb Center for Health Research, Tampa, FL, USA. 3. Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA. 4. Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA. 5. Yale School of Medicine, New Haven, CT, USA. 6. Barbara Davis Center for Childhood Diabetes, Aurora, CO, USA. 7. Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 8. University of California San Francisco, San Francisco, CA, USA.
Abstract
AIM: To assess the associations between demographic and clinical characteristics and sensor glucose metrics in young children with type 1 diabetes, using masked, continuous glucose monitoring data from children aged 2 to < 8 years. RESEARCH DESIGN AND METHODS: The analysis included 143 children across 14 sites in the USA, enrolled in a separate clinical trial. Eligibility criteria were: age 2 to <8 years; type 1 diabetes duration ≥3 months; no continuous glucose monitoring use for past 30 days; and HbA1c concentration 53 to <86 mmol/mol (7.0 to <10.0%). All participants wore masked continuous glucose monitors up to 14 days. RESULTS: On average, participants spent the majority (13 h) of the day in hyperglycaemia (>10.0 mmol/l) and a median of ~1 h/day in hypoglycaemia (<3.9 mmol/l). Participants with minority race/ethnicity and higher parent education levels spent more time in target range, 3.9-10.0 mmol/l, and less time in hyperglycaemia. More time in hypoglycaemia was associated with minority race/ethnicity and younger age at diagnosis. Continuous glucose monitoring metrics were similar in pump and injection users. CONCLUSIONS: Given that both hypo- and hyperglycaemia negatively impact neurocognitive development, strategies to increase time in target glucose range for young children are needed.
AIM: To assess the associations between demographic and clinical characteristics and sensor glucose metrics in young children with type 1 diabetes, using masked, continuous glucose monitoring data from children aged 2 to < 8 years. RESEARCH DESIGN AND METHODS: The analysis included 143 children across 14 sites in the USA, enrolled in a separate clinical trial. Eligibility criteria were: age 2 to <8 years; type 1 diabetes duration ≥3 months; no continuous glucose monitoring use for past 30 days; and HbA1c concentration 53 to <86 mmol/mol (7.0 to <10.0%). All participants wore masked continuous glucose monitors up to 14 days. RESULTS: On average, participants spent the majority (13 h) of the day in hyperglycaemia (>10.0 mmol/l) and a median of ~1 h/day in hypoglycaemia (<3.9 mmol/l). Participants with minority race/ethnicity and higher parent education levels spent more time in target range, 3.9-10.0 mmol/l, and less time in hyperglycaemia. More time in hypoglycaemia was associated with minority race/ethnicity and younger age at diagnosis. Continuous glucose monitoring metrics were similar in pump and injection users. CONCLUSIONS: Given that both hypo- and hyperglycaemia negatively impact neurocognitive development, strategies to increase time in target glucose range for young children are needed.
Authors: Michelle A Van Name; Marisa E Hilliard; Claire T Boyle; Kellee M Miller; Daniel J DeSalvo; Barbara J Anderson; Lori M Laffel; Stephanie E Woerner; Linda A DiMeglio; William V Tamborlane Journal: Pediatr Diabetes Date: 2017-04-21 Impact factor: 4.866
Authors: Steven M Willi; Kellee M Miller; Linda A DiMeglio; Georgeanna J Klingensmith; Jill H Simmons; William V Tamborlane; Kristen J Nadeau; Julie M Kittelsrud; Peter Huckfeldt; Roy W Beck; Terri H Lipman Journal: Pediatrics Date: 2015-03 Impact factor: 7.124
Authors: M Tansey; R Beck; K Ruedy; W Tamborlane; P Cheng; C Kollman; L Fox; S Weinzimer; N Mauras; N H White; E Tsalikian Journal: Pediatr Diabetes Date: 2014-12-11 Impact factor: 4.866
Authors: Paul K Mazaika; Stuart A Weinzimer; Nelly Mauras; Bruce Buckingham; Neil H White; Eva Tsalikian; Tamara Hershey; Allison Cato; Tandy Aye; Larry Fox; Darrell M Wilson; Michael J Tansey; William Tamborlane; Daniel Peng; Mira Raman; Matthew Marzelli; Allan L Reiss Journal: Diabetes Date: 2015-10-28 Impact factor: 9.337
Authors: Naama Barnea-Goraly; Mira Raman; Paul Mazaika; Matthew Marzelli; Tamara Hershey; Stuart A Weinzimer; Tandy Aye; Bruce Buckingham; Nelly Mauras; Neil H White; Larry A Fox; Michael Tansey; Roy W Beck; Katrina J Ruedy; Craig Kollman; Peiyao Cheng; Allan L Reiss Journal: Diabetes Care Date: 2013-12-06 Impact factor: 19.112
Authors: Matthew J Marzelli; Paul K Mazaika; Naama Barnea-Goraly; Tamara Hershey; Eva Tsalikian; William Tamborlane; Nelly Mauras; Neil H White; Bruce Buckingham; Roy W Beck; Katrina J Ruedy; Craig Kollman; Peiyao Cheng; Allan L Reiss Journal: Diabetes Date: 2013-10-29 Impact factor: 9.461
Authors: Gina Agiostratidou; Henry Anhalt; Dana Ball; Lawrence Blonde; Evgenia Gourgari; Karen N Harriman; Aaron J Kowalski; Paul Madden; Alicia H McAuliffe-Fogarty; Molly McElwee-Malloy; Anne Peters; Sripriya Raman; Kent Reifschneider; Karen Rubin; Stuart A Weinzimer Journal: Diabetes Care Date: 2017-12 Impact factor: 19.112
Authors: Anna R Kahkoska; Christina M Shay; Jamie Crandell; Dana Dabelea; Giuseppina Imperatore; Jean M Lawrence; Angela D Liese; Cate Pihoker; Beth A Reboussin; Shivani Agarwal; Janet A Tooze; Lynne E Wagenknecht; Victor W Zhong; Elizabeth J Mayer-Davis Journal: JAMA Netw Open Date: 2018-09-07
Authors: Barbara Kimbell; David Rankin; Ruth I Hart; Janet M Allen; Charlotte K Boughton; Fiona Campbell; Elke Fröhlich-Reiterer; Sabine E Hofer; Thomas M Kapellen; Birgit Rami-Merhar; Ulrike Schierloh; Ajay Thankamony; Julia Ware; Roman Hovorka; Julia Lawton Journal: Pediatr Diabetes Date: 2022-05-25 Impact factor: 3.409
Authors: Marisa E Hilliard; Persis V Commissariat; Lauren Kanapka; Lori M Laffel; Wendy Levy; Kara Harrington; Barbara J Anderson; Kellee M Miller; Linda A DiMeglio Journal: Pediatr Diabetes Date: 2022-05-19 Impact factor: 3.409
Authors: Ruth I Hart; Barbara Kimbell; David Rankin; Janet M Allen; Charlotte K Boughton; Fiona Campbell; Carine de Beaufort; Elke Fröhlich-Reiterer; Julia Ware; Sabine E Hofer; Thomas M Kapellen; Birgit Rami-Merhar; Ajay Thankamony; Roman Hovorka; Julia Lawton Journal: Diabet Med Date: 2022-03-24 Impact factor: 4.213